Sunday, May 22, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Hyderabad | Aurobindo Pharma To Divest Its Us Entity Natrol To New Mountain Capital

Aurobindo Pharma to divest its US entity Natrol to New Mountain Capital

By Telangana Today
Published: Published Date - 10:32 AM, Mon - 26 October 20
The all-cash transaction which is valued at $550 million (4,048 crore) is expected to close by January 2021

Hyderabad: Hyderabad-based Aurobindo Pharma has reached a definitive agreement to sell Natrol LLC., a wholly-owned subsidiary of Aurobindo Pharma USA, Inc., to an affiliate of New Mountain Capital to combine with Jarrow Formulas.

The all-cash transaction is valued at $550 million (or Rs 4,048 crore at the current exchange rate). Subject to customary closing conditions and regulatory approvals, the transaction is expected to close by January 2021.

Natrol’s annual sales for the 12 months ended March 31, 2020 was about $157 million. Following the acquisition of the assets of Natrol by Aurobindo Pharma in December 2014, Natrol has been a consistently profitable business, growing on all fronts under Aurobindo’s ownership.

“Aurobindo is committed to evaluating and concluding strategic options towards focused portfolio enhancement with the ultimate objective of enhancing stakeholder values. We are pleased to sell the Natrol business to an outstanding private equity player, who could focus additional resources to grow Natrol, its products and brands further,” the company said in a statement.

“On behalf of Aurobindo Group, my heartful thanks to all stakeholders including employees, who have supported in acquiring and bringing Natrol to a growth path in the past six years,” said N Govindarajan, MD, Aurobindo Pharma.

He also said “Proceeds from Natrol’s divestiture will be used to reduce debt and other new strategic initiatives.”

Jefferies served as the sole financial advisor to Aurobindo, and Sullivan & Cromwell acted as legal counsel to Aurobindo.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • all-cash transaction
  • Aurobindo Group
  • Aurobindo Pharma
  • Aurobindo Pharma USA

Related News

  • Hyderabad’s Malkam Cheruvu turns idyllic spot

  • Hyderabad: Swanky skywalk to ease pedestrian woes at Mehdipatnam

  • Hyderabad: Woman kills step son at Kachiguda

  • Siddipet: Two youth drown in Kondapochamma Sagar

  • MANUU to organise three-day national conference on Gender and Inclusion

  • YMCA Secunderabad enters semis of Hyderabad Open basketball tournament

Latest News

  • Opinion: Renewables cannot replace coal

    2 hours ago
  • Game On: A return to the basics

    2 hours ago
  • Editorial: Unequal Republic

    2 hours ago
  • AC Milan secure 1st Serie A title in 11 years

    3 hours ago
  • Current Affairs: Who did what and when?

    3 hours ago
  • IPL 2022: PBKS register 5-wicket win over SRH, finish tournament on a high

    3 hours ago
  • Hyderabad: ‘Okati coffee’ will soothe your soul

    3 hours ago
  • Know the Science behind detecting antibodies

    3 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam